Atenolol versus Losartan in Marfan's Syndrome.
Bulat A
BA
Ziganshin
Sandip K
SK
Mukherjee
John A
JA
Elefteriades
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001011:Aorta / Q000187:drug effects*; D001014:Aortic Aneurysm / Q000517:prevention & control*; D001262:Atenolol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D008382:Marfan Syndrome / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D001262:Atenolol; D019808:Losartan